Target Prioritization on BRAF inhibitor case study A375 cell line, Dabrafenib
1Target RankPBIO-AGENT-8B
Evaluation results
| Method | Links | |||
|---|---|---|---|---|
| PBIO-AGENT-8B2026.02 | 1 | 0.161 | 41.3 | |
| Llama-3-8B2026.02 | 4 | -0.11 | -20.1 | |
| Qwen3-30B-A3B2026.02 | 5 | -0.07 | -45.7 |
| Method | Links | |||
|---|---|---|---|---|
| PBIO-AGENT-8B2026.02 | 1 | 0.161 | 41.3 | |
| Llama-3-8B2026.02 | 4 | -0.11 | -20.1 | |
| Qwen3-30B-A3B2026.02 | 5 | -0.07 | -45.7 |